Cosciens Biopharma is now ranked among the top 10 undervalued stocks in the Biotechnology industry on the Toronto Stock Exchange or TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Biotechnology: Biotech and biopharmaceutical companies engaged in research, discovery, development, and production of innovative drug and drugrelated technologies.
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| CSCI | Cosciens Biopharma | 3.95 | 8.05 | 4.10 (103.7%) | 2120 | 10.2 | 0.0 | 0.0 |
| GSD | Devonian Health Gr | 0.18 | 0.36 | 0.18 (98.4%) | 3612 | 26.7 | 0.0 | 0.0 |
| FRX | Fennec Pharmaceuticals | 7.08 | 13.98 | 6.90 (97.5%) | 405 | 193.2 | 0.0 | 0.0 |
| MRVL | Marvel Biosciences | 0.10 | 0.16 | 0.07 (71.8%) | 49561 | 4.3 | 0.0 | 0.0 |
| WAVE | Waverley Pharma | 0.01 | 0.02 | 0.01 (67.4%) | 409 | 0.5 | 0.0 | 0.0 |
| MBX | Microbix Biosystems | 0.35 | 0.57 | 0.22 (63.1%) | 76150 | 47.4 | 0.0 | 25.0 |
| RKV | Rakovina Therapeutics | 0.04 | 0.07 | 0.02 (50.3%) | 304543 | 4.0 | 0.0 | 0.0 |
| XRTX | XORTX Therapeutics | 1.29 | 1.91 | 0.62 (48.3%) | 3796 | 3.7 | 0.0 | 0.0 |
| RVX | Resverlogix | 0.04 | 0.05 | 0.01 (34.8%) | 53033 | 11.1 | 0.0 | 0.0 |
| KNE | Kane Biotech | 0.09 | 0.12 | 0.03 (32.6%) | 29534 | 12.0 | 0.0 | 1.6 |
All data provided as of April 20, 2025.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Cosciens Biopharma
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology. The Company has two reportable and operating segments: Active ingredient and Biopharmaceutical.
Cosciens Biopharma is listed under CSCI on the Toronto Stock Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
/Micron%20Technology%20Inc_%20logo%20on%20building-by%20vzphotos%20vis%20iStock.jpg)